Poniard Pharmaceuticals, Inc.
PARD · OTC
9/30/2011 | 6/30/2011 | 3/31/2011 | 12/31/2010 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $0 | $0 | -$3,246 | -$5,167 |
| Dep. & Amort. | $311 | $317 | $323 | $324 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $652 | $851 | $1,004 | $1,542 |
| Change in WC | $942 | $986 | -$130 | -$2,580 |
| Other Non-Cash | -$3,613 | -$3,836 | $28 | $835 |
| Operating Cash Flow | -$1,708 | -$1,682 | -$2,021 | -$5,046 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$2 | -$7 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $3,032 | $9,207 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$2 | $3,025 | $9,207 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$13,799 |
| Stock Issued | $0 | $0 | $3,184 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$96 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$96 | $0 | -$96 |
| Financing Cash Flow | $0 | -$96 | $3,184 | -$13,895 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,708 | -$1,780 | $4,188 | -$9,734 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,692 | $5,472 | $1,284 | $11,018 |
| End Cash | $1,984 | $3,692 | $5,472 | $1,284 |
| Free Cash Flow | -$1,708 | -$1,684 | -$2,028 | -$5,046 |